These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transfer of endogenous pyrogens across artificial membranes? Lonnemann G; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1998 May; 66():S43-6. PubMed ID: 9573572 [TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes]. Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177 [TBL] [Abstract][Full Text] [Related]
8. Renal replacement therapy in the treatment of acute renal failure-intermittent and continuous. John S; Eckardt KU Semin Dial; 2006; 19(6):455-64. PubMed ID: 17150045 [TBL] [Abstract][Full Text] [Related]
10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
11. [Thermal energy balance during hemodialysis: the role of the filter membrane]. Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045 [TBL] [Abstract][Full Text] [Related]
12. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. Bouman CS; Oudemans-van Straaten HM; Schultz MJ; Vroom MB J Crit Care; 2007 Mar; 22(1):1-12. PubMed ID: 17371737 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391 [TBL] [Abstract][Full Text] [Related]
16. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813 [TBL] [Abstract][Full Text] [Related]